712 unknown. 712 Phase 2, 176 Phase 1, 142 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 712 | Unknown 712 |
| Phase 1 | 176 | Unknown 176 |
| Phase 3 | 142 | Unknown 142 |
Follow Vascular Diseases: new trials by email Literature Review of Vascular Diseases trials Research Report on Vascular Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG Normal saline, Dexmedetomidine, Methylprednisolone - Coronary Artery Disease, Systemic Inflammatory Response Syndrome | Phase 1 / Phase 2 | Unknown | Ain Shams University | 60 | 2025-09-01 | 2025-08-06 |
| Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial Anti-Xa Guided Dosing of Low Molecular Weight Heparin, Standard of Care Dosing - Venous Thromboembolism (VTE), Trauma Related Injuries | Phase 2 / Phase 3 | Unknown | Alexandre Tran | 150 | 2025-01-01 | 2024-10-28 |
| Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke Tirofiban Hydrochloride, Standard medical treatment (SMT) - Acute Stroke, Ischemic Stroke, Acute | Phase 2 / Phase 3 | Unknown | Capital Medical University | 302 | 2024-11-20 | 2024-10-29 |
| Cannabidiol's Role in Dementia Management Cannabidiol Oil - Dementia, Vascular, Dementia, Mixed | Phase 2 / Phase 3 | Unknown | Hospital Pengajar Universiti Putra Malaysia | 486 | 2024-09-01 | 2024-07-23 |
| Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B ) Emergency Stroke Unit based on 0.23-T MRI, Standard stroke unit adherent to guidelines - Ischemic Stroke, Acute | Phase 2 | Unknown | Yongjun Wang | 100 | 2024-08-04 | 2024-08-12 |
| The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage Rapamycin - Communicating Hydrocephalus, Cerebral Intraventricular Hemorrhage | Phase 2 | Unknown | Beijing Tiantan Hospital | 53 | 2024-08-01 | 2024-08-21 |
| Effect of Single-versus Double-limb Cycling Exercise on Blood Flow in Patients With Peripheral Artery Disease Cycle - Peripheral Arterial Disease | Phase 1 / Phase 2 | Unknown | Cairo University | 75 | 2024-07-01 | 2024-07-24 |
| Abdominal Aortic Aneurysm Stabilization With Truncal Cells: Controlled Clinical Trial With Historical Cohorts Allogeneic adipose tissue-derived mesenchymal stem cells - Aortic Aneurysm, Abdominal | Phase 2 | Unknown | Instituto de Investigación Hospital Universitario La Paz | 8 | 2024-06-13 | 2024-07-08 |
| PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG) Erythropoietin, blood transfusion - Anemia, Coronary Disease | Phase 2 | Unknown | Federal University of São Paulo | 120 | 2024-06-01 | 2024-08-07 |
| REMAP ECMO - Beta Receptor Modulation Trial Esmolol - Heart Failure, Cardiogenic Shock | Phase 2 | Unknown | Erasmus Medical Center | 20 | 2024-06-01 | 2024-07-26 |
| European Blood Pressure Intensive Control After Stroke anti-hypertensive, home blood pressure measurement, telemonitoring and medication titration, Standard of Care Blood Pressure Management with Antihypertensives - Ischemic Stroke, Transient Ischemic Attack | Phase 2 | Unknown | University College Dublin | 142 | 2024-05-02 | 2024-07-11 |
| Safety and Efficacy of Stem Cells for Diabetic Foot Ulcer Allogeneic mesenchymal stem cells (MSCs), Normal Saline - Diabetic Foot Ulcer | Phase 1 / Phase 2 | Unknown | Supergenics Life Science Sdn. Bhd. | 22 | 2024-05-01 | 2024-03-06 |
| Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma Anti-BCMA CAR-NK - Multiple Myeloma, Refractory | Phase 1 / Phase 2 | Unknown | Shahid Beheshti University of Medical Sciences | 10 | 2024-04-30 | 2024-03-06 |
| Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI Phentolamine - CA-AKI - Contrast-Associated Acute Kidney Injury, Coronary Artery Disease | Phase 2 / Phase 3 | Unknown | Helwan University | 60 | 2024-03-07 | 2024-03-18 |
| Topical Nitro or Placebo Pre-Cath NitroBid, Placebo - Coronary Artery Disease | Phase 2 | Unknown | Thomas Jefferson University | 256 | 2024-03-01 | 2024-03-04 |
| Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO Patients Faricimab - Age-Related Macular Degeneration, Diabetic Macular Edema | Phase 2 / Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 30 | 2024-03-01 | 2024-08-27 |
| A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma CM313 injection - Multiple Myeloma | Phase 1 / Phase 2 | Unknown | Keymed Biosciences Co.Ltd | 120 | 2024-02-28 | 2023-11-13 |
| A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCI MT1002 Injection - Acute Coronary Syndrome | Phase 2 | Unknown | Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 20 | 2024-02-27 | 2024-08-01 |
| Impact of Early Ventilation in Stroke Outcomes in Patients With Sleep Apnea After First Ever Stroke Adaptive Servoventilation (ASV) therapy, Best medical treatment - Stroke, Sleep Apnea | Phase 2 | Unknown | Philips Portuguesa S.A. | 90 | 2024-02-27 | 2024-08-12 |
| Efficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic Hypotension Routine treatment, add-on low dose Astragalus, add-on high dose Astragalus - Orthostatic Hypotension, Alzheimer Disease | Phase 2 | Unknown | Fujian Medical University Union Hospital | 66 | 2024-02-20 | 2024-01-05 |
Showing 20 of 712. Sign in to see all of them.
Multiple Myeloma (131) · Stroke (82) · Ischemic Stroke (68) · Coronary Artery Disease (51) · Myocardial Infarction (33) · Hypertension (30) · Neoplasms, Plasma Cell (26) · Diabetic Foot (24) · Peripheral Arterial Disease (23) · Myocardial Ischemia (21) · Chronic Limb-Threatening Ischemia (20) · Atherosclerosis (19) · Heart Failure (18) · Lymphoma (18) · Diabetes Mellitus (16)
Cardiovascular Diseases (701) · Pathological Conditions, Signs and Symptoms (246) · Nervous System Diseases (203) · Pathologic Processes (201) · Central Nervous System Diseases (196) · Brain Diseases (195) · Cerebrovascular Disorders (179) · Hemic and Lymphatic Diseases (167) · Hematologic Diseases (158) · Hemorrhagic Disorders (156) · Immune System Diseases (155) · Hemostatic Disorders (148) · Immunoproliferative Disorders (143) · Lymphoproliferative Disorders (143)
Dexamethasone (47) · Bortezomib (27) · Sodium Chloride (23) · Cyclophosphamide (21) · Aspirin (20) · Lenalidomide (15) · Saline Solution (15) · Melphalan (12) · pomalidomide (12) · Thalidomide (10) · daratumumab (10) · Atorvastatin (9) · Clopidogrel (9) · Tissue Plasminogen Activator (8) · Bendamustine Hydrochloride (6)
Capital Medical University (14) · Beijing Tiantan Hospital (12) · Assistance Publique - Hôpitaux de Paris (7) · University of Sao Paulo General Hospital (7) · First Affiliated Hospital of Harbin Medical University (6) · Hadassah Medical Organization (6) · Meshalkin Research Institute of Pathology of Circulation (6) · Samsung Medical Center (6) · University of Calgary (6) · Xijing Hospital (6) · Chang Gung Memorial Hospital (5) · Hellenic Society of Hematology (5) · Seoul National University Hospital (5) · Shahid Beheshti University of Medical Sciences (5) · Thomas Jefferson University (5)
China (160) · United States (103) · Germany (33) · South Korea (32) · Brazil (27) · Canada (26) · France (23) · Netherlands (23) · Italy (22) · Israel (20) · United Kingdom (20) · Iran (16) · Russia (16) · Spain (11) · Taiwan (11)
Antonio Colombo, MD (3) · Evangelos Terpos, Prof (3) · Gang Zhao, M.D. (3) · Sven Poli, Dr. med. (3) · Arnon Nagler, MD (2) · Benedetto Bruno, MD, PhD (2) · Changxi Wang, M.D., Ph.D (2) · David G. Savage, MD (2) · Evgeny Pokushalov, MD, PhD (2) · Gregory A Harshfield, PhD (2) · Gunnar Tepe, MD (2) · Henrik Gregersen, MD (2) · Jun Li, MD (2) · Suzin Mayerson, PhD (2) · Vladimir Dzavik, MD (2)
PMID 42573020, PMID 17090774, PMID 19118718, PMID 21709062, PMID 29386200, PMID 33175411, PMID 37870112, PMID 38648030, PMID 40260835, PMID 9462531, PMID 10811917, PMID 11105983, PMID 11231246, PMID 12473676, PMID 12493255, PMID 12510709, PMID 12628952, PMID 12748199, PMID 1342820, PMID 15107815, PMID 15131807, PMID 15141377, PMID 15189396, PMID 15309575, PMID 15583741, PMID 15711856, PMID 15842354, PMID 15890495, PMID 15978266, PMID 16037216, PMID 16103468, PMID 16282547, PMID 16336965, PMID 16427380, PMID 16475046, PMID 16574919, PMID 16810473, PMID 17138963, PMID 17360989, PMID 17509235, PMID 17825712, PMID 17859247, PMID 18094721, PMID 18211362, PMID 18239868, PMID 18272892, PMID 18276714, PMID 18289410, PMID 18289548, PMID 18468545
2019 (5), 2014 (3), 2015 (3), 2005 (2), 2016 (2), 2018 (2), 2008 (1), P30CA138292 (1), P30GM103341 (1), R01AG043398 (1), R01HD068712 (1), R44HD065388 (1), R44NS060192 (1)